Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Naproxen sodium |
Is a |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Naproxen measurement |
Component |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen poisoning |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Accidental naproxen poisoning |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Intentional naproxen poisoning |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
intoxication par le naproxène d'intention indéterminée |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen adverse reaction |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Allergy to naproxen (finding) |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Naproxen overdose |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Accidental naproxen overdose |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Intentional naproxen overdose |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
surdose de naproxène d'intention indéterminée |
Causative agent (attribute) |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Product containing precisely naproxen 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Naproxen 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Naproxen 375mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Naproxen 25 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Product containing precisely naproxen 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Product containing precisely naproxen 200 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Product containing precisely naproxen 375 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Naproxen 500mg tablet and misoprostol 200micrograms tablet pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Product containing misoprostol and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing lansoprazole and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Lansoprazole 15mg m/r capsule/naproxen 375mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Lansoprazole 15mg m/r capsule/naproxen 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Product containing naproxen and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen sodium 220mg/pseudoephedrine 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Adverse reaction to naproxen |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Aleve 200mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Naproxen 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Intentional naproxen poisoning |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen 200mg/pseudoephedrine 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Lansoprazole 15mg m/r capsule/naproxen 250mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Naproxen-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Accidental poisoning by naproxen |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Esomeprazole magnesium 20mg + naproxen 375mg delayed release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Esomeprazole magnesium 20mg + naproxen 500mg delayed release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Product containing esomeprazole magnesium and naproxen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Allergy to naproxen (finding) |
Causative agent (attribute) |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 200 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 200 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 375 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 375 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen 200 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
|
Naproxen 200mg/pseudoephedrine 120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
|
Product containing precisely naproxen 500 milligram/1 each conventional release rectal suppository (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each gastro-resistant oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 200 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen 200 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen 375 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing naproxen and sumatriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen- and sumatriptan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing esomeprazole and naproxen in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing esomeprazole and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen 25 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen 25 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Esomeprazole and naproxen only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing only naproxen and sumatriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing only lansoprazole and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing only misoprostol and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing only naproxen and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen and sumatriptan only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Naproxen only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing only naproxen in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing only esomeprazole and naproxen in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen (as naproxen sodium) 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely naproxen (as naproxen sodium) 200 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naproxen (substance) |
Inferred relationship |
Some |
1 |